Invests in
Locations:
Min Investment:
$10,000,000.00Max Investment:
$350,000,000.00Target Investment:
$25,000,000.00
Skills
Education
- Uo
- MH
Lists including Scott
Investments
Forta
Total Funding: $55M
EmployerDirect Healthcare
Total Funding: $92M
IDOVEN
Total Funding: $13M
Rhyme
Total Funding: $25M
Leal Health
Total Funding: $20M
Swift Medical
Total Funding: $57M
Medical Informatics
Total Funding: $29M
Subtle Medical
Total Funding: $52M
Work Experience
2021
Managing Director, Healthcare
2021
Investing in and serving founders rebuilding healthcare, now as part of the world's best venture capital culture that is Insight Partners. Every stage, every time zone.
2021 - 2022
Founder and GP, Clay VC
2021 - 2022
Clay VC is a new early-stage investing firm rebuilding the future of healthcare by finding and serving founders at the intersection of deep tech, data, and empathy. We call this next era Computational Care. Based in Palo Alto, CA and serving founders globally. (This description is not a solicitation for investment or investment advice)
2020 - 2021
Partner
2020 - 2021
Building a special purpose diverse team to invest in and serve founders who themselves are technical, ambitious, and building the future of healthcare in the US and globally
2020 - 2020
Investor
2020 - 2020
Jumped in to help catalyze & fund Fred Turner and a wonderful team to rapidly build a COVID19 Diagnostic oral-liquid diagnostic test
2019 - 2020
Board Observer
2019 - 2020
Next-generation blood tests for early cancer detection powered by a machine-driven, multiomics platform. DCVC investor since 2015; Board Observer since July 2019
2019 - 2020
Board Director
2019 - 2020
Building the future of urgent care
2018 - 2020
Investor
2018 - 2020
FDA compliance and submission offered as a machine-driven SaaS service
2018 - 2020
Board Observer
2018 - 2020
"We build machines that read and write"
2018 - 2020
Board Director
2018 - 2020
Computer vision at the bedside, on the smartphone, solving wound care
2017 - 2020
Investor
2017 - 2020
Deep leaning to drastically improve imaging infrastructure, in PET and MR